These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8569097)

  • 21. Recombinant hirudin in patients with chronic, stable coronary artery disease. Safety, half-life, and effect on coagulation parameters.
    Zoldhelyi P; Webster MW; Fuster V; Grill DE; Gaspar D; Edwards SJ; Cabot CF; Chesebro JH
    Circulation; 1993 Nov; 88(5 Pt 1):2015-22. PubMed ID: 8222093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of recombinant hirudin and heparin as an anticoagulant in a cardiopulmonary bypass model.
    Walenga JM; Bakhos M; Messmore HL; Koza M; Wallock M; Orfei E; Fareed J; Pifarre R
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):105-11. PubMed ID: 1772977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators.
    Circulation; 1994 Oct; 90(4):1631-7. PubMed ID: 7923645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variations in the circulating heparin levels during maintenance hemodialysis in patients with end-stage renal disease.
    Kaneva K; Bansal V; Hoppensteadt D; Cunanan J; Fareed J
    Clin Appl Thromb Hemost; 2013; 19(4):449-52. PubMed ID: 23463188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study.
    Greinacher A; Völpel H; Janssens U; Hach-Wunderle V; Kemkes-Matthes B; Eichler P; Mueller-Velten HG; Pötzsch B
    Circulation; 1999 Jan 5-12; 99(1):73-80. PubMed ID: 9884382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial.
    Antman EM
    Circulation; 1996 Sep; 94(5):911-21. PubMed ID: 8790025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. r-Hirudin inhibits platelet-dependent thrombosis during cardiopulmonary bypass in baboons.
    van Wyk V; Neethling WM; Badenhorst PN; Kotzé HF
    J Cardiovasc Surg (Torino); 1998 Oct; 39(5):633-9. PubMed ID: 9833724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anticoagulant therapy with recombinant hirudin in patients with thrombopenia induced by heparin].
    Schiele F; Vuillemenot A; Mouhat T; Kieffer Y; Anguenot T; Bernard Y; Bassand JP
    Presse Med; 1996 May 4-11; 25(16):757-60. PubMed ID: 8692751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis.
    Skagerlind MSE; Stegmayr BG
    Eur J Clin Pharmacol; 2018 Mar; 74(3):267-274. PubMed ID: 29198062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ecarin clotting time but not aPTT correlates with PEG-hirudin plasma activity.
    Moser M; Ruef J; Peter K; Kohler B; Gulba DC; Paterna N; Nordt T; Kübler W; Bode C
    J Thromb Thrombolysis; 2001 Oct; 12(2):165-9. PubMed ID: 11729368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of lepirudin in patients with heparin-induced thrombocytopenia and renal failure requiring hemodialysis.
    Dager WE; White RH
    Ann Pharmacother; 2001; 35(7-8):885-90. PubMed ID: 11485140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant hirudin is a heparin alternative in cardiac surgery.
    Riess FC; Bleese N; Kormann J; Pötzsch B; Madlener K; Müller-Berghaus G; Greinacher A
    J Cardiothorac Vasc Anesth; 1997 Jun; 11(4):538-9. PubMed ID: 9188012
    [No Abstract]   [Full Text] [Related]  

  • 33. Removal of lepirudin, a recombinant hirudin, by hemodialysis, hemofiltration, or plasmapheresis.
    Willey ML; de Denus S; Spinler SA
    Pharmacotherapy; 2002 Apr; 22(4):492-9. PubMed ID: 11939684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial.
    Topol EJ; Fuster V; Harrington RA; Califf RM; Kleiman NS; Kereiakes DJ; Cohen M; Chapekis A; Gold HK; Tannenbaum MA
    Circulation; 1994 Apr; 89(4):1557-66. PubMed ID: 8149521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hirudin versus heparin for anticoagulation in continuous renal replacement therapy.
    Vargas Hein O; von Heymann C; Lipps M; Ziemer S; Ronco C; Neumayer HH; Morgera S; Welte M; Kox WJ; Spies C
    Intensive Care Med; 2001 Apr; 27(4):673-9. PubMed ID: 11403068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of ecarin chromogenic assay and prothrombinase induced clotting time in the monitoring of lepirudin for the treatment of heparin-induced thrombocytopenia.
    Guy S; Kitchen S; Laidlaw S; Cooper P; Woolley A; Maclean R
    Br J Haematol; 2008 Jul; 142(3):466-8. PubMed ID: 18510685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits.
    Agnelli G; Pascucci C; Cosmi B; Nenci GG
    Thromb Haemost; 1990 Apr; 63(2):204-7. PubMed ID: 2363121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antithrombotic and anticoagulant effects of a synthetic tripeptide and recombinant hirudin in various animal models.
    Bacher P; Walenga JM; Iqbal O; Bajusz S; Breddin K; Fareed J
    Thromb Res; 1993 Aug; 71(4):251-63. PubMed ID: 8236155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of recombinant tissue-type plasminogen activator thrombolysis with a selective factor Xa inhibitor derived from the leech Hirudo medicinalis: comparison with heparin and hirudin in a rabbit thrombosis model.
    Kornowski R; Eldor A; Werber MM; Ezov N; Zwang E; Nimrod A; Chernine A; Finkelstein A; Panet A; Laniado S; Keren G
    Coron Artery Dis; 1996 Dec; 7(12):903-9. PubMed ID: 9116933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.